We are live on ! Find out more
SHI

SV Health Investors Portfolio holdings

AUM $32.3M
1-Year Est. Return 20.15%
This Fund
S&P 500
This Quarter Est. Return
-13.04%
1 Year Est. Return
-20.15%
3 Year Est. Return
+97.4%
5 Year Est. Return
+328.26%
10 Year Est. Return
AUM
$99M
AUM Growth
-$34.8M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
6
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 95.18%
2 Miscellaneous 4.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENTL
1
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
$63.8M 64.37%
3,489,533
ATXS
2
DELISTED
Astria Therapeutics
ATXS
$10.6M 10.68%
47,628
OCUL icon
3
Ocular Therapeutix
OCUL
$2.38B
$9.57M 9.66%
1,932,607
ASXC
4
DELISTED
Asensus Surgical, Inc.
ASXC
$9.21M 9.3%
580,515
RPTP
5
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
$4.77M 4.82%
888,132
EVAR
6
DELISTED
Lombard Medical, Inc.
EVAR
$1.17M 1.19%
1,077,499

Similar funds

SV Health Investors's Q2 2016 Portfolio in Review

As of Q2 2016, SV Health Investors held 6 positions worth $99M, down 26% from $134M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2016: portfolio turnover was 0%. SV Health Investors opened no new positions and made no exits, leaving the 6-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, down from 97% a quarter earlier, followed by Miscellaneous.

  • SV Health Investors's ten largest holdings make up 100% of its $99M portfolio in Q2 2016.
  • SV Health Investors opened 0 new positions and closed 0 in Q2 2016.
  • SV Health Investors's portfolio value fell 26% quarter-over-quarter to $99M.

Based on SV Health Investors's 13F filing for Q2 2016, filed 12 Aug 2016.